FEM1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.618400E-01
Normal-vs-Stage2
3.191000E-01
Normal-vs-Stage3
9.088300E-02
Normal-vs-Stage4
1.881630E-01
Stage1-vs-Stage2
2.018800E-01
Stage1-vs-Stage3
1.203610E-01
Stage1-vs-Stage4
2.668600E-01
Stage2-vs-Stage3
2.259200E-01
Stage2-vs-Stage4
9.353400E-01
Stage3-vs-Stage4
3.093600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.558200E-01
Normal-vs-AfricanAmerican
4.114400E-01
Normal-vs-Asian
4.501800E-01
Caucasian-vs-AfricanAmerican
9.342800E-01
Caucasian-vs-Asian
9.284000E-01
AfricanAmerican-vs-Asian
9.868600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.381600E-01
Normal-vs-Female
6.787000E-01
Male-vs-Female
2.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.169200E-01
Normal-vs-Age(41-60Yrs)
8.084400E-01
Normal-vs-Age(61-80Yrs)
4.107200E-01
Normal-vs-Age(81-100Yrs)
3.969400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.755800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.317800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.727800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.580200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.475600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.803600E-02
Normal-vs-Daily Drinker
4.336000E-01
Normal-vs-Weekly Drinker
4.070600E-01
Normal-vs-Occasional Drinker
9.795400E-01
Normal-vs-Social Drinker
9.226200E-01
Non Drinker-vs-Daily Drinker
2.917600E-01
Non Drinker-vs-Weekly Drinker
1.724630E-01
Non Drinker-vs-Occasional Drinker
5.075800E-02
Non Drinker-vs-Social Drinker
3.012200E-02
Daily Drinker-vs-Weekly Drinker
8.182200E-01
Daily Drinker-vs-Occasional Drinker
2.297400E-01
Daily Drinker-vs-Social Drinker
1.453020E-01
Weekly Drinker-vs-Occasional Drinker
3.544400E-01
Weekly Drinker-vs-Social Drinker
2.272800E-01
Occasional Drinker-vs-Social Drinker
8.390800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.709000E-01
Normal-vs-Grade 2
7.226400E-01
Normal-vs-Grade 3
7.233400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.131000E-01
Grade 1-vs-Grade 3
1.201010E-01
Grade 1-vs-Grade 4
3.709000E-01
Grade 2-vs-Grade 3
9.933800E-01
Grade 2-vs-Grade 4
7.226400E-01
Grade 3-vs-Grade 4
7.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.008000E-01
Normal-vs-NonDiabetic
6.628200E-01
Diabetic-vs-NonDiabetic
6.656400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.891000E-01
Normal-vs-NoPancreatitis
5.282800E-01
Pancreatitis-vs-NoPancreatitis
8.728200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.659000E-01
Normal-vs-N1
3.474000E-01
N0-vs-N1
2.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.824000E-01
Normal-vs-TP53-NonMutant
9.818800E-01
TP53-Mutant-vs-TP53-NonMutant
2.188300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
